Question

Difficulty: MediumGynecologic Infections

A 23-year-old nulligravid woman presents to the emergency department with severe, worsening right-sided pelvic pain. Three days ago, she was diagnosed with pelvic inflammatory disease (PID) at an urgent care clinic, where she received a single dose of intramuscular ceftriaxone and was prescribed oral doxycycline and metronidazole. She reports worsening pain, subjective fevers, and an inability to tolerate the oral medications due to severe nausea. Her temperature is 39.0°C (102.2°F). Pelvic examination reveals exquisite cervical motion tenderness and a palpable, tender 5-cm mass in the right adnexa. A point-of-care urine pregnancy test is negative. Arrange the following steps in the most appropriate, evidence-based sequence for the ongoing management of this patient.

  1. 1Perform transvaginal ultrasonography to evaluate for a tubo-ovarian abscess
  2. 2Admit the patient to the hospital for inpatient care
  3. 3Initiate an intravenous broad-spectrum antibiotic regimen
  4. 4Observe clinical response for 48 to 72 hours on medical therapy
  5. 5Evaluate the need for image-guided or surgical percutaneous drainage

Answer

The correct sequence is: transvaginal ultrasonography, hospital admission, initiation of intravenous antibiotics, observation for 48-72 hours, and finally, evaluation for percutaneous drainage if medical therapy fails.
The correct sequence reflects the standard of care for a patient presenting with complicated pelvic inflammatory disease (PID) who has failed outpatient therapy. The presence of a new palpable adnexal mass and persistent fever despite initial antibiotic therapy raises high suspicion for a tubo-ovarian abscess (TOA). Because a pregnancy test was negative, the immediate next step is transvaginal ultrasonography to definitively diagnose and characterize the mass. Once a TOA is suspected or confirmed, the patient must be admitted to the hospital due to the severity of the condition and her inability to tolerate oral medications. The cornerstone of initial TOA management is the prompt administration of intravenous broad-spectrum antibiotics. Although a TOA is an abscess, first-line management for unruptured TOAs is medical, not surgical. The patient should be monitored closely; image-guided percutaneous drainage or surgical intervention is reserved for patients who fail to demonstrate clinical improvement (e.g., persistent fever, worsening pain) after a 48- to 72-hour trial of intravenous antibiotics, or for those presenting with signs of rupture.

Step-by-Step Solution

1
Identify the likely complication based on the physical exam and clinical history.
Suspected tubo-ovarian abscess (TOA)
The presence of a new palpable adnexal mass and failure of outpatient PID therapy strongly indicate a TOA.
2
Confirm the diagnosis.
Transvaginal ultrasound
Imaging is required to definitively diagnose and characterize the adnexal mass in the setting of acute pelvic pain.
3
Determine the appropriate clinical setting for treatment.
Hospital admission
A suspected TOA and the inability to tolerate oral medications are absolute indications for inpatient management.
4
Select the initial therapeutic intervention.
Intravenous antibiotics
First-line therapy for an unruptured TOA is medical, utilizing intravenous broad-spectrum antibiotics.
5
Establish criteria for procedural intervention.
Monitor for 48-72 hours before considering drainage
Drainage is reserved for cases refractory to initial medical management or in the event of suspected rupture.

Key Concept

The management of complicated pelvic inflammatory disease involving a tubo-ovarian abscess requires definitive imaging, hospital admission for intravenous antibiotics, and a 48- to 72-hour trial of medical therapy prior to considering invasive drainage.
Estimated Time:1m 0s
Rate this question